Current trends of targeted therapy for oral squamous cell carcinoma

H Li, Y Zhang, M Xu, D Yang - Journal of cancer research and clinical …, 2022 - Springer
Oral squamous cell carcinoma (OSCC) is a malignant disease in the world which has a
profound effect on human health and life quality. According to tumor stage and pathological …

Advantages of the combinatorial molecular targeted therapy of head and neck cancer—A step before anakoinosis-based personalized treatment

R Kleszcz - Cancers, 2023 - mdpi.com
Simple Summary Head and Neck Squamous Cell Carcinoma (HNSCC) is a major threat to
public health around the world. Its occurrence is linked to genetic events and environmental …

Lipid metabolism reprogramming in head and neck cancer

J Liang, L Li, L Li, X Zhou, Z Zhang, Y Huang… - Frontiers in …, 2023 - frontiersin.org
Lipid metabolism reprogramming is one of the most prominent metabolic anomalies in
cancer, wherein cancer cells undergo dysregulation of lipid metabolism to acquire adequate …

Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients

AM van Harten, R Shah, DV de Boer, M Buijze, M Kreft… - Oncogenesis, 2024 - nature.com
Fanconi anemia (FA) is a rare hereditary disease resulting from an inactivating mutation in
the FA/BRCA pathway, critical for the effective repair of DNA interstrand crosslinks (ICLs) …

Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation

LJ Wils, M Buijze, M Stigter-van Walsum, A Brink… - Cells, 2024 - mdpi.com
Precancerous cells in the oral cavity may appear as oral potentially malignant disorders, but
they may also present as dysplasia without visual manifestation in tumor-adjacent tissue. As …

[HTML][HTML] Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors

R Uhlig, M Abboud, N Gorbokon, M Lennartz… - Annals of Diagnostic …, 2022 - Elsevier
Abstract Cytokeratin 10 (CK10) is a type I acidic low molecular weight cytokeratin which is
mainly expressed in keratinizing squamous epithelium of the skin. Variable levels of CK10 …

KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors

S Kind, CP Castillo, R Schlichter, N Gorbokon… - BMC cancer, 2024 - Springer
Kallikrein-related peptidase 7 (KLK7) is a chymotrypsin-like serine protease which is
essential for the desquamation of corneocytes and thus plays a pivotal role in maintaining …

An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell …

A Oyelakin, J Sosa, KB Nayak, A Glathar, C Gluck… - NAR …, 2023 - academic.oup.com
Although numerous putative oncogenes have been associated with the etiology of head and
neck squamous cell carcinoma (HNSCC), the mechanisms by which these oncogenes and …

[HTML][HTML] Prognostic and clinicopathological role of pretreatment systemic immune-inflammation index in patients with oral squamous cell carcinoma: a meta-analysis

J Zhang, S Dai - Frontiers in Oncology, 2024 - frontiersin.org
Background There are many studies regarding the use of systemic immune-inflammation
index (SII) to help predict oral squamous cell carcinoma (OSCC) prognosis, but findings …

[PDF][PDF] Treatment Intensification in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: What Are the Options and for Whom?

JB Vermorken - Critical Issues in Head and Neck Oncology: Key …, 2023 - library.oapen.org
About two-thirds of the patients with head and neck squamous cell carcinoma present with
locoregionally advanced disease (LA-HNSCC). These patients have a 5-year overall …